Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.

Godínez JM, Tous S, Baixeras N, Moreno-Crespi J, Alejo M, Lejeune M, Bravo IG, Bosch FX, de Sanjosé S.

Infect Agent Cancer. 2011 Nov 18;6:23. doi: 10.1186/1750-9378-6-23.

2.

High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.

Geraets DT, Heideman DA, de Koning MN, Snijders PJ, van Alewijk DC, Meijer CJ, van Doorn LJ, Quint WG.

J Clin Virol. 2009 Nov;46 Suppl 3:S21-6. doi: 10.1016/S1386-6532(09)70297-5.

PMID:
20129070
3.

High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products.

Geraets DT, Heideman DA, de Koning MN, Snijders PJ, Meijer CJ, van Doorn LJ, Quint WG.

J Clin Virol. 2009 Nov;46 Suppl 3:S16-20. doi: 10.1016/S1386-6532(09)70296-3.

PMID:
20129069
4.

Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.

Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C.

J Virol Methods. 2009 Mar;156(1-2):77-83. doi: 10.1016/j.jviromet.2008.11.002. Epub 2008 Dec 17.

PMID:
19041893
5.

Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.

Rao A, Sandri MT, Sideri M, Young S, Sharma A, Behrens C.

J Clin Virol. 2013 Sep;58(1):161-7. doi: 10.1016/j.jcv.2013.06.041. Epub 2013 Jul 27.

PMID:
23895930
6.

Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.

Ngou J, Gilham C, Omar T, Goumbri-Lompo O, Doutre S, Michelow P, Kelly H, Didelot MN, Chikandiwa A, Sawadogo B, Delany-Moretlwe S, Meda N, Costes V, Mayaud P, Segondy M.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):162-8. doi: 10.1097/QAI.0000000000000428.

PMID:
25394189
7.

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.

Lindemann ML, Dominguez MJ, de Antonio JC, Sandri MT, Tricca A, Sideri M, Khiri H, Ravet S, Boyle S, Aldrich C, Halfon P.

J Mol Diagn. 2012 Jan;14(1):65-70. doi: 10.1016/j.jmoldx.2011.09.005. Epub 2011 Nov 10.

PMID:
22079749
9.
11.

Evaluation of the compatibility of the Digene media when performing the Roche linear array human papillomavirus genotyping test.

Hong JH, Lee JK, Song ES, Lee JM, Kim MK.

Arch Gynecol Obstet. 2009 Oct;280(4):613-8. doi: 10.1007/s00404-009-0974-7. Epub 2009 Feb 20.

PMID:
19229548
12.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
13.

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.

Ogilvie GS, Cook DA, Taylor DL, Rank C, Kan L, Yu A, Mei W, van Niekerk DJ, Coldman AJ, Krajden M.

Vaccine. 2013 Feb 4;31(7):1129-33. doi: 10.1016/j.vaccine.2012.09.085. Epub 2012 Dec 25.

PMID:
23273510
14.

Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.

Park Y, Lee E, Choi J, Jeong S, Kim HS.

J Clin Microbiol. 2012 Jul;50(7):2359-65. doi: 10.1128/JCM.00337-12. Epub 2012 Apr 18.

15.

Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test.

Wong FK, Ching JC, Chow JK.

Open Virol J. 2010 Nov 3;4:169-74. doi: 10.2174/1874357901004010169.

16.

Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.

Wong OG, Lo CK, Chow JN, Tsun OK, Szeto E, Liu SS, Ngan HY, Cheung AN.

J Clin Microbiol. 2012 May;50(5):1691-7. doi: 10.1128/JCM.05933-11. Epub 2012 Feb 15.

17.

Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.

Didelot MN, Boulle N, Damay A, Costes V, Segondy M.

J Med Virol. 2011 Aug;83(8):1377-82. doi: 10.1002/jmv.22148.

PMID:
21678441
18.

Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test.

Schopp B, Holz B, Zago M, Stubenrauch F, Petry KU, Kjaer SK, Iftner T.

J Med Virol. 2010 Apr;82(4):605-15. doi: 10.1002/jmv.21719.

PMID:
20166179
19.

Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.

Yu S, Kwon MJ, Lee EH, Park H, Woo HY.

J Med Virol. 2015 Sep;87(9):1587-93. doi: 10.1002/jmv.24206. Epub 2015 Apr 24.

PMID:
25914215
20.

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M.

J Clin Microbiol. 2006 Jun;44(6):2141-6.

Supplemental Content

Support Center